Abionic Announces FDA Registration for World’s Most Rapid Allergy  Test and abioSCOPE® Diagnostic Testing Platform   Test detects sensitization to four common respiratory allergens in United States Scheduled to be commercially available in the US in 2018 Source: businesswire.com - October 20, 2017 01:00 AM Eastern Daylight Time LAUSANNE, Switzerland--(BUSINESS WIRE)--Abionic SA, a developer of disrupter